How community pharmacy can create capacity in Secondary Care

How community pharmacy can create capacity in Secondary Care

It is a widely held belief that the pharmaceutical sector needs to understand the challenges faced by its colleagues in Acute Trusts. Secondary Care...
Why patient trust is key to the success of a Covid-19 vaccine

Why patient trust is key to the success of a Covid-19 vaccine

As the COVID-19 pandemic shows no signs of relenting, the number of patients and hospital admissions is again on the up. Across the UK,...
How new approaches to patient care can ease pressure on the NHS

How new approaches to patient care can ease NHS pressures

There is no doubt that COVID-19 has changed the world, forever. This is particularly true of the NHS and patient care. Going forward, care...
How NHS funding and finances are changing patient pathways

How NHS funding and finances are changing patient pathways

COVID-19 has been a catalyst for change in NHS finance where a new ‘system-level’ funding arrangement has been introduced in England. This sees providers...
Community pharmacy as the front door

Community pharmacy as the front door

We’re facing a very tough winter. No matter where you are, or what you do, the COVID-19 pandemic is affecting the health of us...
COVID-19 and the counterfeit drug crisis

COVID-19 and the counterfeit drug crisis

The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
Scaling up a Covid-19 vaccine

Distribution and scaling up a Covid-19 vaccine

The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
Implications of early COVID-19 vaccine data

Implications of early COVID-19 vaccine data

News this week has largely been dominated by talk about a COVID-19 vaccine and finnCap’s Rude Health Life Sciences Sector Report is one of...
Ten top tips to avoid data breaches

Ten top tips for pharma and healthcare to avoid data breaches

Every organisation is a software organisation but for healthcare providers and pharmaceutical organisations, the stakes are high when it comes to data breaches. In...
The importance of security for medical device firms

The importance of security for medical device firms

With news hitting the headlines that global pharmaceutical company Pfizer Inc. has suffered a huge data breach and in light of National Cyber Security...

Latest articles

Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GlaxoSmithKline (GSK) have reported positive interim Phase II clinical trial safety and immunogenicity data for Medicago’s plant-derived COVID-19 vaccine candidate, which has...
Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

The Sanofi and GlaxoSmithKline (GSK) COVID-19 vaccine candidate has achieved positive results in all adult age groups in a Phase II study with 722...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Challenges in recruiting during the pandemic

Challenges in recruiting during the pandemic

Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

The Sanofi and GlaxoSmithKline (GSK) COVID-19 vaccine candidate has achieved positive results in all adult age groups in a Phase II study with 722...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription